Pharmira Laboratories, Inc. completed the acquisition of US subsidiary Handa Pharmaceuticals, LLC., and its affiliate company Hangzhou Handa Pharmaceutical Technology Co. Ltd. in China.
- Handa Pharmaceuticals Announces TruPharma’s U.S. Launch Of Its FDA-Approved ANDA for Lamotrigine Extended Release Tablets
- Handa Pharmaceuticals, Inc. Announces FDA Approval for Generic Version of AstraZeneca’s SEROQUEL XR® Extended Release Tablets
- Emerging Markets listing in Taiwan
- Taiwan Authorities Approve Public Issuance of Handa Stock
- Handa Pharmaceuticals Announces Endo Begins Shipping Generic Version of AstraZeneca’s SEROQUEL XR®